Management of heartburn not responding to proton pump inhibitors

被引:234
|
作者
Fass, R. [1 ]
Sifrim, D. [2 ]
机构
[1] Univ Arizona, Neuroenter Clin Res Grp, So Arizona VA Hlth Care Syst, Tucson, AZ 85723 USA
[2] Catholic Univ Louvain, Ctr Gastroenterol Res, B-3000 Louvain, Belgium
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; DILATED INTERCELLULAR SPACES; MULTICHANNEL INTRALUMINAL IMPEDANCE; ESOPHAGEAL SPHINCTER RELAXATIONS; GABA(B) AGONIST BACLOFEN; GASTRIC-ACID-SECRETION; EOSINOPHILIC ESOPHAGITIS; BARRETTS-ESOPHAGUS; DOUBLE-BLIND; FOLLOW-UP;
D O I
10.1136/gut.2007.145581
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with gastro-oesophageal reflux disease (GORD) who are not responding to proton pump inhibitors (PPIs) given once daily are very common. Various underlying mechanisms have been shown to contribute to the failure of PPI treatment. These include weakly acidic reflux, duodenogastro-oesophageal reflux, residual acid reflux and functional heartburn, as well as others. Diagnostic evaluation of patients with GORD who have failed PPI treatment may include an upper endoscopy, pH testing and oesophageal impedance with pH monitoring. Commonly, doubling the PPI dose or switching to another PPI will be pursued by the treating physician. Failure of such a therapeutic strategy may result in the addition of a transient lower oesophageal sphincter reducer or pain modulator. Anti-reflux surgery may be suitable for a subset of carefully studied patients.
引用
收藏
页码:295 / 309
页数:15
相关论文
共 50 条